Eagle Bay Advisors’s Boston Scientific BSX Stock Holding History

Eagle Bay Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-315	Closed	-$30K	–	153
2025 Q4	$30K	Buy	+315	New	+$30.9K	0.02%	206
2025 Q1	–	Sell	-356	Closed	-$31.8K	–	235
2024 Q4	$31.8K	Hold	356	–	–	0.02%	399
2024 Q3	$29.8K	Buy	356 +29	+9%	+$2.29K	0.01%	545
2024 Q2	$25.2K	Sell	327 -39	-11%	-$2.85K	0.02%	415
2024 Q1	$25.1K	Buy	366 +309	+542%	+$19.9K	0.02%	396
2023 Q4	$3.29K	Hold	57	–	–	﹤0.01%	695
2023 Q3	$3.01K	Hold	57	–	–	﹤0.01%	727
2023 Q2	$3.08K	Hold	57	–	–	﹤0.01%	721
2023 Q1	$2.85K	Hold	57	–	–	﹤0.01%	726
2022 Q4	$2.64K	Hold	57	–	–	﹤0.01%	735
2022 Q3	$2K	Sell	57 -305	-84%	-$12.2K	﹤0.01%	747
2022 Q2	$13.5K	Buy	+362	New	+$14.7K	0.01%	605
2022 Q1	–	Sell	-308	Closed	-$13K	–	389
2021 Q4	$13K	Sell	308 -254	-45%	-$10.7K	0.01%	651
2021 Q3	$24K	Buy	562 +309	+122%	+$13.7K	0.01%	580
2021 Q2	$11K	Buy	+253	New	+$10.6K	0.01%	659

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eagle Bay Advisors's BSX Position: Q1 2026 in Review

Eagle Bay Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 315 shares — an estimated $30K sold.

Eagle Bay Advisors first reported a position in BSX in Q2 2021 and held it in 15 quarters. The position peaked at $31.8K in Q4 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Eagle Bay Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Eagle Bay Advisors sold 315 Boston Scientific shares in Q1 2026, an estimated $30K.
Eagle Bay Advisors first reported a position in Boston Scientific in Q2 2021 and held it in 15 quarters.
Eagle Bay Advisors's Boston Scientific position peaked at $31.8K in Q4 2024.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Eagle Bay Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.